![]() | Up a level |
Chiapponi, Costanza, Hartmann, Milan J. M., Hescheler, Daniel A., Riemann, Burkhard and Alakus, Hakan (2022). Risk of Malignancy after Radioiodine Therapy for Hyperthyroidism. Onkologe, 28 (4). S. 347 - 349. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415
Hescheler, Daniel A., Riemann, Burkhard, Hartmann, Milan J. M., Michel, Maximilian, Faust, Michael, Bruns, Christiane J., Alakus, Hakan and Chiapponi, Costanza ORCID: 0000-0002-4681-2835
(2021).
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Front. Endocrinol., 12.
LAUSANNE:
FRONTIERS MEDIA SA.
ISSN 1664-2392
Hescheler, Daniel Alexander, Hartmann, Milan Janis Michael, Riemann, Burkhard, Michel, Maximilian, Bruns, Christiane Josephine, Alakus, Hakan and Chiapponi, Costanza (2022). Anaplastic thyroid cancer: genome-based search for new targeted therapy options. Endocr. Connect., 11 (4). BRISTOL: BIOSCIENTIFICA LTD. ISSN 2049-3614
Hescheler, Daniel Alexander, Hartmann, Milan Janis Michael, Riemann, Burkhard, Michel, Maximilian, Bruns, Christiane Josephine, Alakus, Hakan ORCID: 0000-0002-3889-3276 and Chiapponi, Costanza
ORCID: 0000-0002-4681-2835
(2022).
Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging Options.
Cancers, 14 (11).
BASEL:
MDPI.
ISSN 2072-6694
Kraemer, Jan Alexander, Schmid, Kurt Werner, Dralle, Henning, Dietlein, Markus, Schicha, Harald, Lerch, Hartmut, Gerss, Joachim, Frankewitsch, Thomas, Schober, Otmar and Riemann, Burkhard (2010). Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trial. Eur. J. Endocrinol., 163 (4). S. 637 - 645. BRISTOL: BIOSCIENTIFICA LTD. ISSN 1479-683X